MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.celrep.2025.115760

Медицинская библиотека · Cell reports · 2025

Designed miniproteins potently inhibit and protect against MERS-CoV.

Ragotte Robert J, Tortorici M Alejandra, Catanzaro Nicholas J, Addetia Amin, Coventry Brian, Froggatt Heather M, Lee Jimin, Stewart Cameron, Brown Jack T, Goreshnik Inna, Sims Jeremiah N, Milles Lukas F, Wicky Basile I M, Glögl Matthias, Gerben Stacey, Kang Alex, Bera Asim K, Sharkey William, Schäfer Alexandra, Harkema Jack R, Baric Ralph S, Baker David, Veesler David

СтатьяПеревод пока не подготовлен

Аннотация

Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen with a 36% case-fatality rate in humans. No vaccines or specific therapeutics are currently approved for use in humans or the camel host reservoir. Here, we computationally designed monomeric and homo-oligomeric miniproteins that bind with high affinity to the MERS-CoV spike (S) glycoprotein, the main target of neutralizing antibodies and vaccine development. We show that these miniproteins broadly neutralize a panel of MERS-CoV S variants, spanning the known antigenic diversity of this pathogen, by targeting a conserved site in the receptor-binding domain (RBD). The miniproteins directly compete with binding of the dipeptidylpeptidase 4 (DPP4) receptor to MERS-CoV S, thereby blocking viral attachment to the host entry receptor and subsequent membrane fusion. Intranasal administration of a lead miniprotein provides prophylactic protection against stringent MERS-CoV challenge in mice, motivating its future clinical development as a next-generation countermeasure against this virus with pandemic potential.

Для цитирования: Ragotte Robert J, Tortorici M Alejandra, Catanzaro Nicholas J, Addetia Amin, Coventry Brian, Froggatt Heather M, Lee Jimin, Stewart Cameron, Brown Jack T, Goreshnik Inna, Sims Jeremiah N, Milles Lukas F, Wicky Basile I M, Glögl Matthias, Gerben Stacey, Kang Alex, Bera Asim K, Sharkey William, Schäfer Alexandra, Harkema Jack R, Baric Ralph S, Baker David, Veesler David. Designed miniproteins potently inhibit and protect against MERS-CoV.. Cell reports. 2025. DOI: 10.1016/j.celrep.2025.115760.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.